LEMAITRE VASCULAR INC LMAT
NASDAQ Price as of Nov 17, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026
Market cap
$1.74B
P/E (GAAP, TTM)
27.58
P/E (operating)
33.39
Dividend yield
1.2%
Revenue growth YoY
11.3%
EPS growth YoY
-13.3%
ROIC
14.3%
Piotroski F-score
7
Three ways to read the P/E
P/E (GAAP, TTM)
27.58
Net income of the last 4 quarters. Includes investment gains and one-time items.
P/E (GAAP, annual)
30.20
Net income of the latest fiscal year. Includes investment gains and one-time items.
P/E (operating)
33.39
After-tax operating income only: the core business.
P/E (excl. gains)
30.16
Net income after removing identified investment and asset-sale gains.
How it has changed
Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.
| Metric | 2026Q3 | 2026Q2 | Change QoQ | 2025Q3 | Change YoY |
|---|---|---|---|---|---|
| Revenue growth YoY (qtr) | 9.6% | 11.2% | -1.6 pts | 15.0% | -5.4 pts |
| EPS growth YoY (qtr) | 23.3% | 41.7% | -18.3 pts | 15.4% | +7.9 pts |
| Revenue growth (TTM) | 11.8% | 13.3% | -1.4 pts | 14.1% | -2.3 pts |
| EPS growth (TTM) | 39.5% | 38.1% | +1.4 pts | 22.8% | +16.8 pts |
| P/E (GAAP, TTM) | 28.90 | 35.28 | -6.38 | — | — |
| P/E (operating) | 36.34 | 42.19 | -5.85 | — | — |
| P/E (excl. gains) | 32.82 | 38.11 | -5.29 | — | — |
| P/B | 4.82 | 5.59 | -0.78 | — | — |
| ROIC | 14.3% | 14.3% | 0.0 pts | 13.0% | +1.3 pts |
| Net margin | 23.1% | 23.1% | 0.0 pts | 20.0% | +3.1 pts |
| Dividend yield | 1.1% | 0.9% | +0.2 pts | — | — |
| EPS (TTM) | 2.86 | 2.72 | +5.1% | 2.05 | +39.5% |
| Price | $82.65 | $95.96 | -13.9% | — | — |
History by quarter-end
Reported quarters
| Quarter ended | Revenue | QoQ | YoY | EPS | QoQ | YoY | Net margin |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $67.97M | -3.4% | 11.3% | 0.65 | -12.2% | -13.3% | 22.1% |
| Jun 30, 2026 | $70.38M | 5.8% | 9.6% | 0.74 | 8.8% | 23.3% | 24.2% |
| Mar 31, 2026 | $66.55M | 3.3% | 11.2% | 0.68 | -1.4% | 41.7% | 23.6% |
| Dec 31, 2025 * | $64.45M | 5.6% | 15.7% | 0.69 | -8.0% | 43.8% | 24.2% |
| Sep 30, 2025 | $61.05M | -5.0% | 11.4% | 0.75 | 25.0% | 53.1% | 28.4% |
| Jun 30, 2025 | $64.23M | 7.3% | 15.0% | 0.60 | 25.0% | 15.4% | 21.5% |
| Mar 31, 2025 | $59.87M | 7.5% | 12.0% | 0.48 | 0.0% | 9.1% | 18.4% |
| Dec 31, 2024 * | $55.72M | 1.6% | 14.0% | 0.48 | -2.0% | 26.3% | 20.1% |
| Sep 30, 2024 | $54.82M | -1.8% | 15.6% | 0.49 | -5.8% | 48.5% | 20.3% |
| Jun 30, 2024 | $55.85M | 4.4% | 11.4% | 0.52 | 18.2% | 44.4% | 21.2% |
| Mar 31, 2024 | $53.48M | 9.4% | 13.6% | 0.44 | 15.8% | 63.0% | 18.5% |
| Dec 31, 2023 | $48.88M | 3.1% | 19.4% | 0.38 | 15.2% | 52.0% | 17.3% |
* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.
All figures
Price & size
| Fiscal year end | Dec 31, 2025 | End date of the latest annual (10-K) report used. |
|---|---|---|
| Price date | Nov 17, 2026 | Date of the latest closing price used. |
| Price | $76.11 | Latest closing price. |
| Market cap | $1.74B | Price × shares outstanding. |
| Enterprise value | $1.71B | Market cap + debt − cash: the price of the whole business. |
| Shares | 22.88M | Shares outstanding used for market cap. |
Valuation
| P/E (GAAP, annual) | 30.20 | Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative. |
|---|---|---|
| P/E (GAAP, TTM) | 27.58 | Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items. |
| P/E (operating) | 33.39 | Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items. |
| P/E (operating, TTM) | 30.36 | Market cap ÷ after-tax operating income of the last four quarters. |
| P/E (excl. gains) | 30.16 | Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified. |
| PEG | 0.77 | P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap. |
| PEG (TTM) | 1.42 | TTM P/E ÷ TTM EPS growth rate (in %). |
| Earnings yield | 3.3% | Net income ÷ market cap. The inverse of the P/E. |
| Earnings yield (TTM) | 3.6% | TTM EPS ÷ price. |
| P/B | 4.43 | Market cap ÷ shareholders' equity. Blank when equity is negative. |
| P/S | 6.98 | Market cap ÷ revenue of the latest fiscal year. |
| P/S (TTM) | 6.47 | Market cap ÷ revenue of the last four quarters. |
| P/FCF | 23.39 | Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative. |
| EV/EBITDA | 21.87 | Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels. |
| EV/EBIT | 25.23 | Enterprise value ÷ operating income. |
| EV/Sales | 6.86 | Enterprise value ÷ revenue. |
| Book value / share | 17.20 | Shareholders' equity ÷ shares. |
| FCF yield | 4.3% | Free cash flow ÷ market cap. |
Operating vs. one-time earnings
| Operating EPS | 2.28 | After-tax operating income per share (latest fiscal year). |
|---|---|---|
| Investment gains | — | Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified. |
| Asset-sale gains | $0 | One-time gains or losses from selling property, assets or businesses. Blank = none identified. |
| Non-operating income | $7.27M | Pre-tax income minus operating income: interest, investment results and one-time items combined. |
| Gains as % of net income | 0.0% | Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains. |
Latest quarter & trailing 12 months
| Latest quarter | Sep 30, 2026 | End date of the most recent reported quarter. |
|---|---|---|
| Revenue (qtr) | $67.97M | Revenue of the latest reported quarter. |
| Net income (qtr) | $15.02M | Net income of the latest reported quarter. |
| EPS (qtr) | 0.65 | Diluted EPS of the latest reported quarter. |
| Revenue growth YoY (qtr) | 11.3% | Latest quarter revenue vs the same quarter a year earlier. |
| Revenue growth QoQ (qtr) | -3.4% | Latest quarter revenue vs the previous quarter. |
| EPS growth YoY (qtr) | -13.3% | Latest quarter EPS vs the same quarter a year earlier. |
| EPS growth QoQ (qtr) | -12.2% | Latest quarter EPS vs the previous quarter. |
| Net income growth YoY (qtr) | -13.5% | Latest quarter net income vs the same quarter a year earlier. |
| Net income growth QoQ (qtr) | -11.9% | Latest quarter net income vs the previous quarter. |
| Gross margin (qtr) | 71.7% | Gross profit ÷ revenue in the latest quarter. |
| Operating margin (qtr) | 26.0% | Operating income ÷ revenue in the latest quarter. |
| Net margin (qtr) | 22.1% | Net income ÷ revenue in the latest quarter. |
| Revenue (TTM) | $269.36M | Revenue of the last four quarters. |
| Net income (TTM) | $63.34M | Net income of the last four quarters. |
| EPS (TTM) | 2.76 | Sum of the last four quarters of diluted EPS. |
| Revenue growth (TTM) | 11.8% | Last four quarters of revenue vs the four quarters before. |
| EPS growth (TTM) | 19.5% | Last four quarters of EPS vs the four quarters before. |
| Net income growth (TTM) | 18.7% | Last four quarters of net income vs the four quarters before. |
Dividends & shareholder returns
| Dividend yield | 1.2% | Dividends paid per share over the last 12 months ÷ price. |
|---|---|---|
| Dividend / share (TTM) | $0.9500 | Dividends per share paid over the last 12 months. |
| Payout ratio | 37.7% | Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings. |
| FCF payout ratio | 24.3% | Dividends ÷ free cash flow. |
| Dividend growth (1y) | 25.0% | Dividends per share vs the same 12-month window a year earlier. |
| Dividend CAGR (3y) | 19.3% | Annualised dividend growth over 3 years. |
| Dividend CAGR (5y) | 16.6% | Annualised dividend growth over 5 years. |
| Payments (12m) | 4 | Number of dividend payments in the last 12 months. |
| Last ex-dividend date | Aug 20, 2026 | Most recent ex-dividend date. |
| Buyback yield | 0.1% | Share repurchases ÷ market cap. |
| Shareholder yield | 1.4% | Dividend yield + buyback yield. |
Profitability
| Gross margin | 71.5% | Gross profit ÷ revenue (latest fiscal year). |
|---|---|---|
| EBITDA margin | 31.4% | EBITDA ÷ revenue. |
| Operating margin | 27.2% | Operating income ÷ revenue. |
| Net margin | 23.1% | Net income ÷ revenue. |
| FCF margin | 29.8% | Free cash flow ÷ revenue. |
| ROE | 14.7% | Return on equity: net income ÷ shareholders' equity. Blank when equity is negative. |
| ROA | 9.4% | Return on assets: net income ÷ total assets. |
| ROIC | 14.3% | Return on invested capital: after-tax operating income ÷ (equity + debt − cash). |
Growth (annual)
| Revenue growth (annual) | 13.5% | Latest fiscal year revenue vs the year before. |
|---|---|---|
| Net income growth (annual) | 31.1% | Latest fiscal year net income vs the year before. |
| EPS growth (annual) | 30.6% | Latest fiscal year diluted EPS vs the year before. |
| Revenue CAGR (3y) | 15.6% | Annualised revenue growth over 3 fiscal years. |
| EPS CAGR (3y) | 39.4% | Annualised EPS growth over 3 fiscal years. |
Financial health
| Current ratio | 12.89 | Current assets ÷ current liabilities. Above 1 means short-term bills are covered. |
|---|---|---|
| Quick ratio | 12.89 | (Current assets − inventory) ÷ current liabilities. |
| Cash ratio | 0.78 | Cash ÷ current liabilities. |
| Debt / equity | 0.00 | Total debt ÷ shareholders' equity. Blank when equity is negative. |
| Debt / assets | 0.00 | Total debt ÷ total assets. |
| Debt / EBITDA | 0.00 | Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt. |
| Net debt / EBITDA | -0.36 | (Debt − cash) ÷ EBITDA. Negative means more cash than debt. |
| Interest coverage | 13.10 | Operating income ÷ interest expense. |
Earnings quality
| FCF conversion | 129.0% | Free cash flow ÷ net income. Above 100% means profits turn into real cash. |
|---|---|---|
| Accruals ratio | -3.8% | (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings. |
| Stock comp % revenue | 3.1% | Share-based compensation ÷ revenue. |
| R&D % revenue | 5.7% | Research & development spending ÷ revenue. |
| SG&A % revenue | — | Selling, general & administrative expense ÷ revenue. |
| Tax rate used | 23.2% | Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown). |
Efficiency
| Asset turnover | 0.41 | Revenue ÷ total assets. |
|---|---|---|
| Days sales outstanding | 49 | Average days to collect payment from customers. |
| Days inventory | — | Average days inventory is held. |
| Days payables | 19 | Average days to pay suppliers. |
Trading & momentum
| 52-week high | $118.01 | Highest price in the last 52 weeks. |
|---|---|---|
| 52-week low | $75.67 | Lowest price in the last 52 weeks. |
| From 52-week high | -35.5% | How far below the 52-week high the price is (0% = at the high). |
| Above 52-week low | 0.6% | How far above the 52-week low the price is. |
| Avg volume (30d) | 121.30K | Average shares traded per day over the last 30 days. |
| Avg $ volume (30d) | $9.96M | Average dollars traded per day over the last 30 days: a liquidity measure. |
Scores
| Piotroski F-score | 7 | Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail. |
|---|---|---|
| Altman Z-score | 6.73 | Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers. |
Reported figures (latest fiscal year)
| Revenue | $249.60M | Revenue of the latest fiscal year. |
|---|---|---|
| Net income | $57.73M | Net income of the latest fiscal year. |
| Diluted EPS | 2.52 | Diluted earnings per share of the latest fiscal year. |
| EBITDA | $78.33M | Operating income + depreciation & amortization. |
| Free cash flow | $74.47M | Operating cash flow − capital spending. |
| Total debt | $0 | Long-term plus current debt. |
| Cash | $28.24M | Cash and equivalents. |
| Equity | $393.52M | Shareholders' equity. |
| Total assets | $615.69M | Total assets. |